Sessions & Tracks
Overview
The Global Summit on Cancer Advances (GSCA 2026), hosted by ResearchRiser.org, offers a transformative program of tracks and sessions that push the boundaries of cancer research and care. Held in a fully virtual format online from September 16–18, 2026, these sessions connect global experts, clinicians, and innovators to Elevate Knowledge, Connect Globally. Explore the diverse tracks below, each designed to inspire collaboration and address pressing oncology challenges.
Cancer Biology & Genomics
Focus: Exploring the molecular and genomic foundations of cancer.
- Tumor Microenvironment & Metastasis
- Genomic Profiling & Mutational Landscapes
- Cancer Stem Cells & Signaling Pathways
- Molecular Mechanisms of Resistance
Target Audience: Researchers, geneticists, oncologists.
Immuno-Oncology & Cancer Vaccines
Focus: Harnessing the immune system to combat cancer.
- CAR-T Cell Therapy
- Immune Checkpoint Inhibitors
- Tumor-Infiltrating Lymphocytes (TILs)
- Neoantigen Vaccines & mRNA Technology
Target Audience: Immunologists, oncologists, vaccine developers.
Clinical Oncology & Therapeutics
Focus: Advancing patient care through innovative treatments.
- Advancements in Chemotherapy & Radiotherapy
- Personalized Medicine in Oncology
- Multimodal Cancer Therapy Approaches
- Management of Treatment-Related Toxicity
Target Audience: Clinicians, oncologists, therapists.
Translational Research & Drug Development
Focus: Bridging lab discoveries to clinical applications.
- Preclinical Cancer Models
- AI/ML in Drug Discovery
- Combination Therapies
- Clinical Trials: Phase I–III Updates
Target Audience: Researchers, pharmacologists, clinical trial specialists.
Neurological & Brain Cancers
Focus: Innovations in brain cancer research and treatment.
- Glioblastoma and Astrocytoma Innovations
- Blood–Brain Barrier Drug Delivery
- Pediatric Neuro-Oncology
- Neuroimaging Biomarkers
Target Audience: Neuro-oncologists, pediatric oncologists, radiologists.
Rare Cancers & Orphan Tumors
Focus: Addressing unique challenges in rare cancer care.
- Sarcomas and Rare Solid Tumors
- Rare Blood Malignancies
- Genetic Syndromes Linked to Rare Cancers
- Global Registries and Patient Advocacy
Target Audience: Rare disease experts, oncologists, patient advocates.
Global Oncology & Disparities
Focus: Tackling global cancer care inequities.
- Cancer Care in LMICs
- Disparities in Cancer Screening and Outcomes
- Global Cancer Burden and Strategies
- WHO/UN Initiatives and Policy Frameworks
Target Audience: Public health experts, policymakers, global health advocates.
Nursing, Palliative, & Psychosocial Oncology
Focus: Enhancing patient support and holistic care in oncology.
- Cancer Pain Management & Palliative Interventions
- Oncology Nursing Practices & Burnout
- Psychosocial Support & Survivorship
- Ethical Dilemmas in End-of-Life Care
Target Audience: Nurses, palliative care specialists, psychologists.
Liquid Biopsy, Biomarkers & Early Detection
Focus: Advancing early detection through innovative diagnostics.
- ctDNA and Circulating Tumor Cells
- Predictive & Prognostic Markers
- Multi-Cancer Early Detection (MCED) Tests
- Point-of-Care Diagnostics
Target Audience: Diagnostic specialists, oncologists, researchers.
Artificial Intelligence & Digital Oncology
Focus: Leveraging technology for oncology advancements.
- AI for Imaging and Pathology
- Predictive Modeling & Prognosis Tools
- Digital Therapeutics & Remote Monitoring
- Blockchain in Health Data Management
Target Audience: Technologists, data scientists, healthcare innovators.
Precision Oncology & Personalized Treatment
Focus: Tailoring treatments to individual patients.
- Targeted Therapies (e.g., PARP, BRAF, KRAS Inhibitors)
- NGS-Guided Treatment Algorithms
- Liquid Biopsy-Driven Therapy Adjustment
- Tumor Boards and AI-Assisted Decisions
Target Audience: Oncologists, geneticists, clinical researchers.
Lifestyle, Nutrition & Cancer Prevention
Focus: Reducing cancer risk through proactive measures.
- Cancer Epidemiology & Prevention Strategies
- Diet, Microbiome & Cancer Interaction
- Smoking Cessation and HPV Vaccination
- Environmental Carcinogens & Policies
Target Audience: Public health experts, nutritionists, policymakers.
Stay Informed: Program Overview | Contact Us